The World Health Organisation has suspended testing malaria drug, Hydroxychloroquine, in COVID-19 patients due to safety concerns.
WHO Director-General, Tedros Adhanom Ghebreyesus, in a virtual press conference on Monday, said the decision came after the publication last week of a study indicating that using the drug on COVID-19 patients could increase their likelihood of dying.
Hydroxycholoroquine has been touted by United States President, Donald Trump, and others as a possible treatment for the disease.
Trump had said he was taking the drug to help prevent infection.
“The executive group has implemented a temporary pause of the Hydroxychloroquine arm within the solidarity trial while the safety data is reviewed by the data safety monitoring board,” Ghebreyesus said.
- Delta State Ministry of Technical Education Massive Recruitment Graduates
- Urgent Vacancies in Warri for Receptionist and Laundry Man
- Current UBA Bank Recruitment For May 2021
- NGO Jobs in Lagos for Monitoring and Evaluation Officer at DNA Learning Solutions
- Job Vacancies at Kano University of Science and Technology, Wudil
- University of Delta Agbor Massive Recruitment for Academic Staff
- Citibank Nigeria Limited Recruitment for Credit Risk Senior Analyst